Binh Dinh Pharmaceutical and Medical Equipment JSC (HOSE:DBD)

HOSE:DBD Income Statement

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	1,865,380	1,727,548	1,651,770	1,554,821	1,558,504
Revenue Growth (YoY)	7.98%	4.59%	6.24%	-0.24%	23.99%
Cost of Revenue	981,001	894,975	853,250	787,170	935,939
Gross Profit	884,379	832,573	798,520	767,652	622,566
Selling, General & Admin	558,103	526,981	501,538	494,312	405,437
Operating Expenses	558,103	526,981	501,538	494,312	405,437
Operating Income	326,276	305,592	296,982	273,339	217,129
Interest Expense	-3,847	-4,058	-6,998	-1,916	-1,325
Interest & Investment Income	20,036	11,605	11,635	8,733	5,137
Earnings From Equity Investments	12,280	27,063	28,704	24,786	16,083
Currency Exchange Gain (Loss)	2,644	-947.49	-482.96	354.16	733.11
Other Non Operating Income (Expenses)	-11,308	-12,119	-9,753	-6,739	-5,310
EBT Excluding Unusual Items	346,082	327,136	320,086	298,558	232,448
Gain (Loss) on Sale of Investments	-	-2,000	-	-	-
Pretax Income	346,082	325,136	320,086	298,558	232,448
Income Tax Expense	54,142	49,954	51,031	55,003	43,324
Net Income	291,940	275,182	269,055	243,555	189,124
Preferred Dividends & Other Adjustments	40,918	38,525	37,668	34,098	26,477
Net Income to Common	251,022	236,656	231,387	209,457	162,646
Net Income Growth	6.09%	2.28%	10.47%	28.78%	19.80%
Shares Outstanding (Basic)	94	94	94	94	94
Shares Outstanding (Diluted)	94	94	94	94	94
Shares Change (YoY)	0.34%	-	-0.00%	-	-0.07%
EPS (Basic)	2673.96	2529.63	2473.31	2238.88	1738.52
EPS (Diluted)	2673.96	2529.63	2473.00	2238.88	1738.52
EPS Growth	5.71%	2.29%	10.46%	28.78%	17.16%
Free Cash Flow	206,614	115,985	148,663	82,184	62,932
Free Cash Flow Per Share	2200.91	1239.77	1589.06	878.47	672.68
Dividend Per Share	-	2000.000	-	1600.000	-
Gross Margin	47.41%	48.19%	48.34%	49.37%	39.95%
Operating Margin	17.49%	17.69%	17.98%	17.58%	13.93%
Profit Margin	13.46%	13.70%	14.01%	13.47%	10.44%
Free Cash Flow Margin	11.08%	6.71%	9.00%	5.29%	4.04%
EBITDA	375,841	353,705	342,951	315,005	255,818
EBITDA Margin	20.15%	20.47%	20.76%	20.26%	16.41%
D&A For EBITDA	49,565	48,112	45,970	41,665	38,689
EBIT	326,276	305,592	296,982	273,339	217,129
EBIT Margin	17.49%	17.69%	17.98%	17.58%	13.93%
Effective Tax Rate	15.64%	15.36%	15.94%	18.42%	18.64%
Revenue as Reported	1,865,380	1,727,548	1,651,770	1,554,821	1,558,504

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.